Roche Holding AG (RHHBY) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Drug Manufacturers - General industria. La empresa tiene su sede en Basel, Switzerland. El CEO actual es Thomas Schinecker.
RHHBY tiene fecha de IPO 2003-08-20, 103,249 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $328.61B.
Roche Holding AG is a Swiss multinational pharmaceutical and diagnostics company founded in 1896 and headquartered in Basel. The company develops and markets pharmaceutical products across multiple therapeutic areas including oncology, neuroscience, immunology, cardiovascular and metabolism, ophthalmology, and respiratory diseases, as well as treatments for conditions such as cancer, hemophilia, and inflammatory disorders. In addition to pharmaceuticals, Roche operates a substantial diagnostics business offering in vitro tests for disease diagnosis including cancer, diabetes, COVID-19, and hepatitis, alongside diagnostic instruments and reagents. The company serves patients and healthcare providers across Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and numerous other markets globally.
